Syngeneic graft-versus-host disease after allogeneic bone marrow transplantation and cyclosporine treatment.
Hess
A D
AD
Johns Hopkins Bone Marrow Transplant Unit, Baltimore, MD.
Vogelsang
G B
GB
Silanskis
M
M
Friedman
K A
KA
Beschorner
W E
WE
Santos
G W
GW
D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology; D016026:Bone Marrow Transplantation; D003524:Cyclosporins / Q000008:administration & dosage*; D003602:Cytotoxicity, Immunologic; D006086:Graft vs Host Disease / Q000276:immunology*; D006649:Histocompatibility Antigens / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D007111:Immunity, Cellular; D007116:Immunization, Passive; D051381:Rats
D003524:Cyclosporins; D006649:Histocompatibility Antigens; D000949:Histocompatibility Antigens Class II